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Table I. Effects of hypothermia during preconditioned ischemia-reperfusion  the myocardial protection of 
preconditioning in isolated perfused rat heart 
Cardiac function (% baseline) 
Immediately after PC 45 min after eperfusion 
LDVP +dp/dtmo~ L VDP + dp/dtm~ 
CK activity 
in effluent 
(IU/L) 
Hypothermic preconditioning 
(n = 8, temperature 31° C) 
Normothermic preconditioning 
(n = 8, temperature 37° C) 
87.5 +- 3.17 87.8 +- 3.6? 88.8 -+ 3.17 82.7 + 2.3? 13 + 1.47 
107.5 -+ 3.4 94.6 -+ 2.4 106 + 3.5 103 + 5.2 8.8 -+ 0.8 
Data were presented asmean -+ standard error of the mean. PC, Preconditioning; LVDP, left ventricular developed pressure; dp/dt, he first derivative of
LVDP; CK, creatinine kinase. 
?p < 0.05 versus normothermic preconditioning. 
hypotension, ischemia, and even some inotropic reme- 
dies. 4 These factors should be checked seriously because 
an actual preconditioning may be induced before the 
preconditioned ischemia. Therefore it may be a prerequi- 
site to answer whether the hearts in the experimental 
group were really preconditioned orwhether the hearts in 
the control group were actually preconditioned before the 
evaluation of preconditioning in cardiac surgery. 
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Reply to the Editor." 
We would like to thank Drs. Lu, Ying, and Guo for 
their kind remarks about our paper and share their 
enthusiasm for the study of the untapped endogenous 
cardioprotective mechanisms. We read with interest heir 
report concerning the lesser efficacy of hypothermic pre- 
conditioning in the rat heart. Results presented in the 
study seem to show a lesser benefit of preconditioning 
when induced at a temperature of 31°C followed by 3 
hours of cardiac arrest with hypothermic (4 ° C) crystalloid 
cardioplegic solution and 45 minutes of normothermic 
reperfusion. However, no control group data are pre- 
sented for either the hypothermic or normothermic pre- 
conditioning experiments. Even though there does not 
appear to be any benefit from hypothermic precondition- 
ing on the various hemodynamic parameters measured at 
the end of reperfusion compared with the ones reported 
immediately after preconditioning, there are no data to 
document what would have occurred if preconditioning 
had not been performed in the hypothermic setting. 
Perhaps omitting preconditioning in this situation would 
have caused greater deterioration of the contractility 
indices after reperfusion. We believe that in the experi- 
mental protocol presented, the difference in precondition- 
ing effect should be compared with the appropriate con- 
trol groups, which are hypothermic and normothermic 
nonpreconditioned animals, and the results presented as a 
function of these controls. Baseline hemodynamic data 
recorded before the preconditioning stimulus would also 
be helpful because the baseline parameters may indeed be 
already altered by hypothermia, which is known to affect 
numerous enzymatic pathways. Also, since the second 
time point of study is after 45 minutes of normothermic 
reperfusion, the recovery may be only delayed in the 
hypothermic group compared with the normothermic one 
and measurements at a later time point may be warranted. 
It is noteworthy that recent studies from the first group to 
report a metabolic benefit of preconditioning in clinical 
cardiac surgery, performed in the setting of normothermic 
ventricular fibrillation, failed to show any benefit when the 
preconditioning was induced at lower temperatures, a'2
Ischemic preconditioning may be an interesting adjunct o 
myocardial protection when cardioprotection is subopti- 
mal, such as in long crossclamp times and inadequate 
delivery of cardioplegic solution, situations in which the 
heart is submitted to ischemic arrest rather than aerobic 
arrest. 3 Ischemic preconditioning has been found to con- 
fer equal but no additive benefit o hypothermia outside 
the two situations mentioned above. 4
In our study, although no rigid predictors of precondi- 
tioning ischemia, referred to in the letter, were used, we 
did see occasional electrocardiographic changes during 
induction of ischemia, and creatine kinase MB values and 
lactate gradients at the end of the preconditioning proto- 
col suggested a greater ischemic insult in the precondi- 
tioned group, making us believe that a sufficient ischemic 
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stimulus had indeed been delivered. Our data lead us to 
conclude that the benefits conferred by ischemic precon- 
ditioning before continuous normothermic blood cardio- 
plegia, which results in aerobic ardioplegic arrest in most 
cases, are minimal and perhaps even detrimental, as 
reported by others. 5
Otherwise, we agree with the comments that numerous 
confounding factors may skew the preconditioning effect 
and should be controlled for in both experimental nd 
clinical studies. These include the use of opioid agonists, 
volatile anesthetics, 6 a-adrenergic agonists, aprotinin, and 
cardiopulmonary b pass itself, which all may have precon- 
ditioning effects. 7 
Again we thank Lu, Ying, and Guo for their comments 
and the points they raise in the study of the endogenous 
cardioprotective m chanisms of the heart, which beg to be 
exploited in clinical cardiac surgery. 
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Video-assisted thoracoscopic thymectomy: From 
the right or from the left? 
To the Editor: 
Mack and colleagues I are to be congratulated on their 
excellent multiinstitutional study on video-assisted thora- 
coscopic (VAT) thymectomy, which we prefer to perform 
by the left-sided approach as we have previously de- 
scribed. 2 Although we believe that the thymus can be 
safely approached from either side for VAT techniques, 
we have chosen the left access for a number of reasons, 
including our experience with standard surgical transcer- 
vical and transsternal pproaches)' 4 First, the left side of 
the thymus gland is usually larger, extending down to the 
pericardiophrenic area, and is more frequently affected by 
neoplastic degeneration. Second, the innominate vein 
runs mainly in the left region of the anterosuperior 
mediastinum. Finally, the aortopulmonary window is a 
frequent site of ectopic thymic tissue, as pointed out by 
Jaretzki and Wolf. 5 
It is our impression that all mediastinal perithymic 
tissue, including fat in the aortopulmonary window, can be 
totally removed by the left-sided approach. We routinely 
perform this step in our procedures, considering it essen- 
tial to achieving intentional extended thymectomy. Adju- 
vant pneumomediastinum canbe considered a useful tool 
to facilitate all these surgical maneuvers, whatever the 
VAT approach. We agree that VAT thymectomy is a 
technically advanced procedure that is gaining acceptance 
by both patients and neurologists because of the less 
invasive access and excellent cosmetic results. 1 In accor- 
dance with the intermediate-term esults of Mack and 
colleagues, 1 our preliminary experience based on 12 VAT 
thymectomies seems to suggest equivalent results to those 
provided by conventional surgical techniques. 
However, the effectiveness of VAT thymectomy in 
myasthenia gravis still must be proved by means of a 
larger series of patients and a longer follow-up. For this 
purpose we are now completing a prospective multiinsti- 
tutional trial on VAT thymectomy performed by a sole 
left-sided approach. 
May one really say that VAT thymectomy is preferable 
from the right side? Why not from the left? A multiinsti- 
tutional comparative study based on a homogeneous 
series of patients might answer the question before one 
should decide to insert the thoracoscope through the 
cervical incision, as properly suggested by Cooper. 6
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